WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



Pages:   || 2 |

«What is in this leaflet 1. What Effentora is and what it is used for 2. What you need to knowbefore you use Effentora 3. How to use Effentora 4. ...»

-- [ Page 1 ] --

Package leaflet: Information for the user

Effentora 100 micrograms buccal tablets

Effentora 200 micrograms buccal tablets

Effentora 400 micrograms buccal tablets

Effentora 600 micrograms buccal tablets

Effentora 800 micrograms buccal tablets

Fentanyl

Read all of this leaflet carefully before you start using this medicine because it contains

important information for you.

- Keep this leaflet. You may need to read it again.

- If you have any further questions, ask your doctor or pharmacist.

- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4..

What is in this leaflet

1. What Effentora is and what it is used for

2. What you need to knowbefore you use Effentora

3. How to use Effentora

4. Possible side effects

5. How to store Effentora

6. Contents of the pack and other information

1. What Effentora is and what it is used for The active substance of Effentora is fentanyl citrate. Effentora is a pain-relieving medicine known as an opioid, which is used to treat breakthrough pain in adult patients with cancer who are already taking other opioid pain medicines for their persistent (around-the-clock) cancer pain.

Breakthrough pain is additional, sudden pain that occurs in spite of you having taken your usual opioid pain-relieving medicines.

2. What you need to know before you use Effentora

Do not use Effentora:

• If you are not regularly using a prescribed opioid medicine (e.g codeine, fentanyl, hydromorphone, morphine, oxycodone, pethidine), every day on a regular schedule, for at least a week, to control your persistent pain. If you have not been using these medicines you must not use Effentora, because it may increase the risk that breathing could become dangerously slow and/or shallow, or even stop.

• If you are allergic to fentanyl or any of the other ingredients of this medicine (listed in section 6).

• If you suffer from severe breathing problems or severe obstructive lung conditions.

• If you suffer from short-term pain other than breakthrough pain Warnings and precautions Talk to your doctor or pharmacist before using Effentora.

Keep using the opioid pain medicine you take for your persistent (around-the-clock) cancer pain during your Effentora treatment.

Whilst you are being treated with Effentora, do not use other fentanyl treatments previously prescribed for your breakthrough pain. If you still have some of these fentanyl treatments at home, contact your pharmacist to check how to dispose of them.

100

If you have any of the following, talk to your doctor or pharmacist before starting Effentora:

• Your other opioid pain medicine taken for your persistent (around-the-clock) cancer pain is not stabilised yet.

• You are suffering from any condition that has an effect on your breathing (such as asthma, wheezing, or shortness of breath).

• You have a head injury.

• You have an exceptionally slow heart rate or other heart problems.

• You have liver or kidney problems, as these organs have an effect on the way in which your system breaks down the medicine.

• You have low amount of fluid in the circulation or low blood pressure

• You have problems with your heart especially slow heart rate

• You take antidepressants or antipsychotics, please refer to the section other medicines and Effentora What to do if someone accidentally takes Effentora If you think someone has accidentally taken Effentora please seek immediate medical assistance. Try to keep the person awake until emergency help arrives.

If someone has accidentally taken Effentora, they may have the same side effects as described in the section 3 “If you use more Effentora than you should”.

Children and adolescents Do not give this medicine to children between the ages of 0 and 18 years.

Other medicines and Effentora Tell your doctor or pharmacist before starting Effentora if you are taking or have recently taken or

might take any of the following medicines:

• Any medicines which might normally make you sleepy (have a sedative effect) such as sleeping pills, medicines to treat anxiety, antihistamines, or tranquillisers.

• Any medicines that might have an effect on the way in which your body breaks down Effentora, such as ritonavir, nelfinavir, amprenavir, and fosamprenavir (medicines that help control HIV infection) or other so-called CYP3A4 inhibitors such as ketoconazole, itraconazole, or fluconazole (used for treatment of fungal infections), troleandomycine, clarithromycine, or erythromycine (medicines for treatment of bacterial infections), aprepitant (used for severe nausea) and diltiazem and verapamil (medicines for treatment of high blood pressure or heart diseases).

• Medicines called monoamine-oxidase (MAO) inhibitors (used for severe depression) or have done so in the past 2 weeks.





• Certain type of strong pain killers, calledpartial agonist/antagonists e.g. buprenorphine, nalbuphine and pentazocine (medicines for treatment of pain). You could experience symptoms of withdrawal syndrome (nausea, vomiting, diarrhoea, anxiety, chills, tremor, and sweating) while using these medicines.

• The risk of side effects increases if you are taking medicines such as certain antidepressants or antipsychotics. Effentora may interact with these medicines and you may experience mental status changes (e.g. agitation, hallucinations, coma), and other effects such as body temperature above 38°C, increase in heart rate, unstable blood pressure, and exaggeration of reflexes, muscular rigidity, lack of coordination and/or gastrointestinal symptoms (e.g nausea, vomiting, diarrhoea).

Your doctor will tell you whether Effentora is suitable for you.

Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.

101 Effentora with food and drink and alcohol

• Effentora may be used before or after, but not during, meals. You may drink some water before using Effentora to help moisten your mouth, but you should not drink or eat anything while taking the medicine.

• You should not drink grapefruit juice while using Effentora because it may affect the way your body breaks down Effentora.

• Do not drink alcohol while using Effentora. It can increase the risk of experiencing dangerous side effects.

Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Effentora should not be used during pregnancy unless you have discussed this with your doctor.

You should not use Effentora during childbirth because fentanyl may cause respiratory depression in the new-born child.

Fentanyl can get into breast milk and may cause side effects in the breast-fed infant. Do not use Effentora if you are breast-feeding. You should not start breast-feeding until at least 5 days after the last dose of Effentora.

Driving and using machines You should discuss with your doctor whether it is safe for you to drive, or operate machinery after taking Effentora. Do not drive or operate machinery if you: are feeling sleepy or dizzy; have blurred or double vision; or have difficulty in concentrating. It is important you know how you react to Effentora before driving or operating machinery.

Effentora contains sodium Each tablet of Effentora 100 micrograms contains 10 mg of sodium. Each tablet of Effentora 200 micrograms, Effentora 400 micrograms, Effentora 600 micrograms and Effentora 800 micrograms contains 20 mg of sodium. You should take this into consideration if you are on a controlled sodium diet and seek advice from your doctor.

3. How to use Effentora

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

Dosage and frequency When you first start using Effentora, your doctor will work with you to find the dose that will relieve your breakthrough pain. It is very important that you use Effentora exactly as the doctor tells you The initial dose is 100 micrograms. During determination of your right dose, your doctor may instruct you to take more than one tablet per episode. If your breakthrough pain is not relieved after 30 minutes, use only 1 more tablet of Effentora during the titration period.

Once the right dose has been determined with your doctor, use 1 tablet for an episode of breakthrough pain as a general rule. In the further course of treatment your requirement for analgesic therapy may change. Higher doses may be necessary. If your breakthrough pain is not relieved after 30 minutes, use only 1 more tablet of Effentora during this dose-readjustment period.

Contact your doctor if your right dose of Effentora does not relieve your breakthrough pain. Your doctor will decide if your dose needs to be changed.

Wait at least 4 hours before treating another episode of breakthrough pain with Effentora.

You must let your doctor know immediately if you are using Effentora more than four times per day, as he may change your medicine for your persistent pain. When your persistent pain is controlled again, your doctor may need to change your dose of Effentora. For the most effective relief, let your 102 doctor know about your pain and how Effentora is working for you, so that the dose can be changed if needed.

Do not change doses of Effentora or your other pain medicines on your own. Any change in dosage must be prescribed and monitored by your doctor.

If you are not sure about the right dose, or if you have questions about taking this medicine, you should contact your doctor.

Method of administration Effentora buccal tablets are for oromucosal use. When you place a tablet in your mouth, it dissolves and the medicine is absorbed through the lining of your mouth, into the blood system. Taking the medicine in this way allows it to be absorbed quickly to relieve your breakthrough pain.

Taking the medicine

• Open the blister only when you are ready to use the tablet. The tablet must be used immediately once removed from the blister.

• Separate one of the blister units from the blister card by tearing apart at the perforations.

• Bend the blister unit along the line where indicated.

• Peel the blister backing to expose the tablet. Do NOT attempt to push the tablet through the blister, because this can damage the tablet.

• Remove the tablet from the blister unit and immediately place the entire tablet near a molar tooth between the gum and the cheek (as shown in the picture). Sometimes, your doctor may tell you to place the tablet under your tongue instead.

• Do not attempt to crush or split the tablet.

• Do not bite, suck, chew, or swallow the tablet, as this will result in less pain relief than when taken as directed.

• The tablet should be left between the cheek and gum until dissolved, which usually takes approximately 14 to 25 minutes.

• You may feel a gentle bubbling sensation between your cheek and gum as the tablet dissolves.

• In case of irritation, you may change the placement of the tablet on the gum.

• After 30 minutes, if pieces of the tablet remain, they may be swallowed with a glass of water.

If you use more Effentora than you should

• The most common side effects are feeling sleepy, sick or dizzy. If you begin to feel very dizzy, or very sleepy before the tablet is completely dissolved, rinse your mouth with water and spit the remaining pieces of the tablet into a sink or toilet right away.

–  –  –

If you forget to use Effentora If the breakthrough pain is still ongoing, you may take Effentora as prescribed by your physician. If the breakthrough pain has stopped, do not take Effentora until the next breakthrough pain episode.

If you stop using Effentora You should discontinue Effentora when you no longer have any breakthrough pain. You must however continue to take your usual opioid pain relieving medicine to treat your persistent cancer pain as advised by your doctor. You may experience withdrawal symptoms similar to the possible side effects of Effentora when discontinuing Effentora. If you experience withdrawal symptoms or if you are concerned about your pain relief, you should contact your doctor. Your doctor will evaluate if you need medicine to reduce or eliminate the withdrawal symptoms.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects Like all medicines, this medicine can have side effects, although not everybody gets them. If you notice any of these, contact your doctor.

The most serious side effects are shallow breathing, low blood pressure and shock. Effentora like other fentanyl products can cause very severe breathing problems which can lead to death.

If you become very sleepy or have slow and/or shallow breathing, you or your carer should contact your doctor immediately and call for emergency help.

Very common side effects (may affect more than 1 in 10 people):

• Dizziness, headache

• feeling nauseous, vomiting

• at the site of tablet application: pain, ulcer, irritation, bleeding, numbness, loss of sensation, redness, swelling or spots

Common side effects (may affect up to 1 in 10 people):

• feeling anxious or confused, depression, insomnia

• abnormal taste, weight decreased

• sleepiness, sedation, excessive tiredness, weakness, migraine, numbness, swelling of arms or legs, drug withdrawal syndrome (may manifest by the occurrence of the following side effects nausea, vomiting, diarrhoea, anxiety, chills, tremor, and sweating), shaking, falls, chills



Pages:   || 2 |


Similar works:

«Health Ministry of Ukraine Zaporizhzhya State Medical University Department of internal medicine №2 RHEUMATOLOGY DISEASES. DIAGNOSIS AND MANAGEMENT APPROACHES EXECUTABLE TASK FORCE Zaporizhzhya, 2015 Guidelines ratified on meeting of the Central methodical committee of Zaporizhzhya state medical university (protocol numbers 6 (20.05.2015) and it is recommended for the use in educational process for foreign students. Guidelines were written by: Vizir V.A. Head of the Department,...»

«Measuring Use of the Lactational Amenorrhea Method through the Demographic and Health Surveys: Data Quality and Implications Madeleine Short Fabica and Yoonjoung Choia,b a Office of Population and Reproductive Health, Bureau for Global Health, US Agency for International Development b Corresponding author: 1201 Pennsylvania Avenue, NW, Suite 200, Washington, DC 20004, Tel: 202-808-3889, Email: ychoi@usaid.gov Views and opinions expressed in this paper are the authors’. They do not necessarily...»

«Electrophysiological studies on visual information processing in dyslexia and ADHD Monica Dhar Paranimfs: Fiona Koster Roeljan Wiersema Financial support for the publication of this thesis was provided by the University of Groningen, the Graduate School of Behavioural and Cognitive Neurosciences, EASYCAP, and MedCat medical equipment and accessories. Printed in the Netherlands by Wöhrmann Print Service. © 2009 M. Dhar RIJKSUNIVERSITEIT GRONINGEN Electrophysiological studies on visual...»

«Chapter 2 Psychodynamic Treatment of Panic Disorder Clinical and Research Assessment Frederic N. Busch and Barbara Milrod Introduction Both pharmacological [1–3] and cognitive-behavioral treatments [4–6] of panic disorder have been found to be effective in treatment. Despite this progress, not all patients respond or are able to tolerate these treatments [4–8]. Relapse is frequent if medication is discontinued before a prolonged maintenance phase [9–12]. Questions remain about the...»

«Then the Yak Fell Into The River A Roller Coaster Pilgrimage to Kailash-Manasarovar, Mostly Driving off Road through the Roof of the World SWAMI BODHANANDA (Memoirs of the Mt. Kailash-Manasarovar trip in August 2010 led by Sambodh Foundation) The yak is a symbol of sturdiness, steadiness and nimble footedness. A small scale mammoth or a large hairy bull, a shaded huge black boulder or an oversized leafy bush—your imagination runs riot seeing a yak. It is the animal of Tibet—the friend,...»

«Impact of School Closures on an Influenza Pandemic Scientific Evidence Base Review May 2014 Title: Impact of School Closures on an Influenza Pandemic Scientific Evidence Base Review Author: PH-HPER-ID&BP 10200 Commissioned by the Department of Health and produced by Public Health England Document Purpose: A review of the scientific evidence base of the impact of school closures on an influenza pandemic Publication date: 05/2014 Target audience: Supporting Documents for UK Influenza Pandemic...»

«Guideline for Managing Occupational Health and Safety in an Influenza Pandemic The aim of the guideline is to provide guidance and information from an Occupational Health and Safety perspective to the University community in the event of a pandemic. This Guideline links to the UQ Crisis Management Plan which aims to protect and support students, staff and the general public in crisis situations http://www.uq.edu.au/ohs/oh-s-policies-procedures-guidelines. and to the Managing OHS in an Influenza...»

«BRIEFIN G PAP ER N O. 8 PAG E 1 O F 9 SAM F. HA LABI 04.16.14 THE UNCERTAIN FUTURE OF VACCINE DEVELOPMENT AND DEPLOYMENT FOR INFLUENZA PANDEMICS On December 13, 2013, a joint communique O ’NE IL L INST IT U T E The O’Neill Institute for National issued by seven European and North and Global Health Law at Georgetown University was American governments, Japan, and the established to respond to the need for innovative solutions to the most European Commission noted three influenza pressing...»

«Occupational Therapy Skin Care Guideline Best Practice for the Prevention and Treatment of Pressure Ulcers Created by the Occupational Therapists in Vancouver Coastal Health and Providence Health Care April 2008 OCCUPATIONAL THERAPY SKIN CARE GUIDELINE FOR VCH/PHC BEST PRACTICE FOR THE PREVENTION AND TREATMENT OF PRESSURE ULCERS ACKNOWLEDGEMENTS This guideline has benefited from the contributions of many occupational therapists. We would like to acknowledge the following contributors:...»

«PACKAGE LEAFLET: INFORMATION FOR THE USER Amoxicillin/Clavulanic acid Amneal 500 mg/125 mg film-coated tablets Amoxicillin/Clavulanic acid Amneal 875 mg/125 mg film-coated tablets (Amoxicillin/Clavulanic acid) Read all of this leaflet carefully before you start taking this medicine.Keep this leaflet. You may need to read it again.If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if...»

«Pink Himalayan Salt Top 14 Healing Secrets 1. Fights Diabetes & Normalizes Blood Sugar One of the most vital and crucial benchmark of our body health is our blood sugar level. Having too low or too high a blood sugar has its corresponding disadvantages and if the problem becomes extreme it can be very hard on our body. Chronic high blood sugar can result in developing a disease called diabetes. However, for people who are already diabetic, ample intake of Himalayan salt will put the body into...»

«Glaucoma What You Should Know U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute The National Eye Institute (NEI) conducts and supports research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. NEI is part of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. For more information, contact— National Eye Institute National Institutes of Health 2020...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.